SecSonar.com

Precipio, Inc. (PRPO)

Precipio, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Precipio, Inc. (PRPO) is a Medical - Diagnostics & Research company based in US with a market capitalization of $41.6M. Revenue grew 50.6% year-over-year and the company generated $359K in free cash flow. This page tracks PRPO's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 54 employees · IPO Jun 30, 2017

Valuation

Valuation & price

$26.04 · as of May 17, 2026 · -19.6% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

2.85

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$31.75$22.77$13.80Jul 25Dec 25Jul 26Jul 7, 25$13.98Jul 9, 25$16.20Jul 11, 25$15.58Jul 15, 25$14.78Jul 17, 25$14.19Jul 21, 25$13.90Jul 23, 25$14.68Jul 25, 25$14.70Jul 29, 25$14.45Jul 31, 25$14.26Aug 4, 25$14.51Aug 6, 25$14.58Aug 11, 25$13.80Aug 13, 25$14.29Aug 15, 25$14.70Aug 19, 25$14.30Aug 21, 25$14.50Aug 25, 25$14.19Aug 27, 25$15.26Aug 29, 25$15.52Sep 3, 25$15.80Sep 5, 25$17.74Sep 9, 25$21.25Sep 11, 25$20.23Sep 16, 25$18.41Sep 18, 25$17.57Sep 22, 25$17.25Sep 24, 25$17.58Sep 26, 25$17.42Sep 30, 25$17.79Oct 2, 25$20.85Oct 6, 25$20.21Oct 8, 25$18.35Oct 10, 25$19.04Oct 14, 25$17.00Oct 16, 25$18.65Oct 21, 25$21.67Oct 23, 25$21.92Oct 27, 25$20.85Oct 29, 25$20.66Oct 31, 25$20.50Nov 4, 25$20.07Nov 6, 25$20.29Nov 10, 25$20.24Nov 12, 25$20.00Nov 14, 25$19.33Nov 18, 25$23.38Nov 20, 25$25.62Nov 25, 25$22.28Nov 28, 25$24.33Dec 2, 25$24.56Dec 4, 25$24.61Dec 8, 25$24.86Dec 10, 25$24.17Dec 12, 25$24.97Dec 16, 25$24.02Dec 18, 25$23.19Dec 22, 25$23.10Dec 24, 25$23.89Dec 29, 25$23.18Jan 2, 26$23.82Jan 6, 26$22.98Jan 8, 26$23.09Jan 12, 26$26.06Jan 14, 26$24.00Jan 16, 26$23.50Jan 21, 26$24.69Jan 23, 26$24.55Jan 27, 26$24.50Jan 29, 26$24.26Feb 2, 26$24.75Feb 4, 26$22.72Feb 9, 26$19.80Feb 11, 26$21.50Feb 13, 26$23.39Feb 18, 26$23.82Feb 20, 26$25.36Feb 24, 26$23.65Feb 26, 26$24.30Mar 2, 26$24.68Mar 4, 26$26.83Mar 6, 26$26.53Mar 10, 26$26.50Mar 12, 26$28.78Mar 17, 26$29.35Mar 19, 26$26.93Mar 23, 26$26.93Mar 25, 26$27.24Mar 27, 26$25.97Mar 31, 26$25.00Apr 2, 26$25.40Apr 7, 26$28.50Apr 9, 26$27.82Apr 13, 26$28.05Apr 15, 26$29.49Apr 17, 26$28.30Apr 22, 26$27.99Apr 24, 26$28.00Apr 28, 26$31.75Apr 30, 26$30.90May 4, 26$29.70May 6, 26$29.98May 8, 26$29.81May 12, 26$28.68May 14, 26$28.60May 18, 26$24.95May 20, 26$24.06May 22, 26$23.80May 28, 26$23.34Jun 1, 26$22.53Jun 3, 26$24.04Jun 5, 26$23.49Jun 9, 26$23.32Jun 11, 26$22.63Jun 15, 26$22.44Jun 17, 26$22.36Jun 22, 26$23.25Jun 24, 26$22.96Jun 26, 26$23.31Jul 2, 26$25.20
$13.8052-week range$32.37
Loading valuation history…

Fundamentals

Key fundamentals

$41.6M

Market cap

50.6%

Revenue growth (YoY)

44.5%

Gross margin

$359K

Free cash flow (USD)

-$2.4M

Net debt

Net cash position

9.5%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$1.6MFY 2017$1.7MFY 2018$2.9MFY 2019$3.1MFY 2020$6.1MFY 2021$8.8MFY 2022$9.4MFY 2023$15.2MFY 2024$16.0MFY 2025$24.0M
$1.6M$24M

Free cash flow by year

2016 → 2025

FY 2016$-3.6MFY 2017$-6.8MFY 2018$-6.9MFY 2019$-9.2MFY 2020$-7.6MFY 2021$-7.3MFY 2022$-8.0MFY 2023$-3.7MFY 2024$216.0KFY 2025$359.0K
-$3.6M$359K

Gross margin by year

2021 → 2025

FY 202127.0%FY 202226.7%FY 202339.6%FY 202447.4%FY 202544.5%
27.0%44.5%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

1

Insider buys · 90 days

2

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 14, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 15, 2026Filing
  • Insider sellInsider Sell $23KSANDBERG RICHARD A · Director · $22.5KMay 26, 2026Filing
  • Insider sellInsider Sell $78KSANDBERG RICHARD A · Director · $77.8KMay 21, 2026Filing
  • Quarterly report10-Q FiledMay 14, 2026Filing
  • 8-K eventShareholder Update CallMay 6, 2026Filing
  • Insider buyInsider Buy $531 · 10b5-1 PlanSabet Ahmed Zaki · Chief Operating Officer · $530.7Apr 10, 2026Filing

Questions

Frequently asked questions

What is Precipio, Inc.'s market cap?

Precipio, Inc. (PRPO) has a market capitalization of $41.6M.

What is PRPO's P/E ratio?

A meaningful P/E ratio is not available for PRPO — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is PRPO's price-to-book (P/B) ratio?

PRPO trades at 2.85 times book value per share.

Are insiders buying PRPO stock?

Yes — SEC Form 4 filings show 1 open-market insider buy and 2 sells at Precipio, Inc. in the last 90 days.

Same arena

Related companies in Medical - Diagnostics & Research

STRR

Star Equity Holdings, Inc.

$42.6M

MDXH

MDxHealth S.A.

$40.5M

QUCY

Mainz Biomed N.V.

$33.5M

DRIO

DarioHealth Corp.

$55.2M

VNRX

VolitionRx Limited

$15.6M

NOTV

Inotiv, Inc.

$9.8M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.